Increased serum high-sensitivity C-reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease

Pediatrics International

Volumn 50, Issue 4, 2008, Pages 436-440

  Tomita, Hideshi ^a,b   Takamuro, Motoki ^a   Soda, Wataru ^a   Hatakeyama, Kinya ^a   Tsutsumi, Hiroyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

Author keywords

Brain natriuretic peptide; Congenital heart disease; High sensitivity C reactive protein; Hypoxia

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ANOXIA; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEMOGLOBINS; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; OXYGEN; YOUNG ADULT;

EID: 50249119073     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02581.x     Document Type: Article

References (33)

1. Du Clos TW. Function of C-reactive protein. Ann. Med. 2000 32 : 274 8.
2. Loukovaara M, Leinonen P, Teramo K, Alfthan H, Stenman UH, Andersson S. Fetal hypoxia is associated with elevated cord serum C-reactive protein levels in diabetic pregnancies. Biol. Neonate 2004 85 : 237 42.
3. Charuruks N, Laohajinda B, Rujiwantigum S, Chaiworaporn M. Reference value for C-reactive protein and its distribution pattern in Thai adults. Circ. J. 2005 69 : 339 44.
4. Pepys MB, Berger A. The renaissance of C reactive protein: It maybe a marker not only of acute illness but also of future cardiovascular disease. BMJ 2001 322 : 4 5.
5. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and American heart association. Circulation 2003 107 : 499 511.
6. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 286 : 327 34.
7. Festa A, D'Agostino R Jr., Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 2002 51 : 1131 7.
8. Verma S, Li SH, Badiwala MV et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002 105 : 1890 96.
9. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004 109 : 2058 67.
10. Yin WH, Chen JW, Jen HL et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am. Heart J. 2004 147 : 931 8.
11. Anand IS, Dphil, Latini R et al. C-reactive protein in heart failure. Prognostic value and the effect of Valsartan. Circulation 2005 112 : 1428 34.
12. Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pedersen BK. Hypoxemia increases serum interleukin-6 in humans. Eur. J. Appl. Physiol. 1997 76 : 480 82.
13. Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003 107 : 1129 34.
14. Minoguchi K, Yokoe T, Tazaki T et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2005 172 : 625 30.
15. Levin ER, Garder DG, Samson WK. Natriuretic peptides. N. Engl. J. Med. 1998 339 : 321 8.
16. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J. Am. Coll. Cardiol. 2001 38 : 1934 41.
17. Berger R, Huelsman M, Strecker K et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002 105 : 2392 7.
18. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin. Chem. 2004 50 : 1762 8.
19. Hiura M, Kikuchi T, Nagasaki K, Uchiyama M. Elevation of serum C-reactive protein levels is associated with obesity in boys. Hypertens. Res. 2003 26 : 541 6.
20. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004 90 : 1281 5.
21. Mitani Y, Sawada H, Hayakawa H et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005 111 : 38 43.
22. Itoh K. Validity of BMI as an index of obesity in children. Jpn. J. Pediatr. 2003 56 : 2327 32 (in Japanese).
23. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr. Cardiol. 2004 25 : 336 40.
24. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am. J. Cardiol. 2005 95 : 474 8.
25. Book WM, Hott BJ, McConnell M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am. J. Cardiol. 2005 95 : 545 6.
26. Mir TS, Falkenberg J, Friedrich B et al. Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol. Young 2005 15 : 396 401.
27. Holmgren D, Westerlind A, Lundberg PA, Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin. Physiol. Funct. Imaging 2005 25 : 263 9.
28. Kraiczi H, Magga J, Sun XY, Ruskoaho H, Zhao X, Hedner J. Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J. Appl. Physiol. 1999 87 : 2025 31.
29. Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J. 2004 18 : 1928 30.
30. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004 109 : 2872 7.
31. Visser M, Bouter LM, McQuillian GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999 282 : 2131 5.
32. de P S Soares R, Maeda NY, Bydlowski SP, Lopes AA. Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome. Cardiol. Young 2005 15 : 504 13.
33. Oechslin E, Kiowski W, Schindler R et al. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 2005 112 : 1106 12.